SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-063286
Filing Date
2011-11-14
Accepted
2011-11-14 06:32:45
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v239528_10q.htm 10-Q 632207
2 EXHIBIT 31.1 v239528_ex31-1.htm EX-31.1 11997
3 EXHIBIT 31.2 v239528_ex31-2.htm EX-31.2 12032
4 EXHIBIT 32.1 v239528_ex32-1.htm EX-32.1 5314
5 EXHIBIT 32.2 v239528_ex32-2.htm EX-32.2 5527
  Complete submission text file 0001144204-11-063286.txt   1957244

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tbet-20110930.xml EX-101.INS 199559
7 XBRL TAXONOMY EXTENSION SCHEMA tbet-20110930.xsd EX-101.SCH 12423
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbet-20110930_cal.xml EX-101.CAL 32075
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbet-20110930_def.xml EX-101.DEF 74846
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbet-20110930_lab.xml EX-101.LAB 73543
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbet-20110930_pre.xml EX-101.PRE 81966
Mailing Address 90 JAFFE ROAD ROOM 1701, 17/F WANCHAI K3 00000
Business Address 90 JAFFE ROAD ROOM 1701, 17/F WANCHAI K3 00000 852 9798 5569
TIBET PHARMACEUTICALS, INC. (Filer) CIK: 0001489077 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35038 | Film No.: 111197484
SIC: 2834 Pharmaceutical Preparations